Abstract
Use of measurement-based care (MBC) in depression includes the systematic administration of validated clinical measurement tools to guide the screening, assessment, treatment, and monitoring of clinical outcomes in patients with depression. In clinical practice, MBC can be used to screen for and assess severity of depressive symptoms, and guide treatment selection and change in type of treatment when clinical improvement is insufficient. In addition to identifying depressive symptoms, MBC can also help detect co-existing psychiatric conditions to inform more precise treatment selection. Furthermore, the MBC approach entails regular assessments of symptom severity, adherence, and side effects, which facilitates timely and vigorous dose adjustments of antidepressants to improve clinical outcomes. MBC can also be used to monitor specific symptoms that are associated with poor depression outcomes to allow acute-phase prognostication of treatment outcomes. The authors conclude that the MBC approach has many evidence-based benefits compared to the usual care and should be incorporated into the clinical care of patients with depression. [ Psychiatr Ann. 2023;53(9):395–399.]
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
